Endocrinol Metab.  2018 Jun;33(2):305-306. 10.3803/EnM.2018.33.2.305.

The Association between Persistent Hypertriglyceridemia and the Risk of Diabetes Development: The Kangbuk Samsung Health Study (Endocrinol Metab 2018;33:55–61, Yu Hyun Kwon et al.)

• Seo MH

• KMID: 2420501
• DOI: http://doi.org/10.3803/EnM.2018.33.2.305

Abstract

No abstract available.

MeSH Terms

Hypertriglyceridemia*

Reference

1. Subramanian S, Chait A. Hypertriglyceridemia secondary to obesity and diabetes. Biochim Biophys Acta. 2012; 1821:819–825. PMID: 22005032.

2. Berglund L, Brunzell JD, Goldberg AC, Goldberg IJ, Sacks F, Murad MH, et al. Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012; 97:2969–2989. PMID: 22962670.

3. Kwon YH, Kim SK, Cho JH, Kwon H, Park SE, Oh HG, et al. The association between persistent hypertriglyceridemia and the risk of diabetes development: the Kangbuk Samsung Health Study. Endocrinol Metab (Seoul). 2018; 33:55–61. PMID: 29388400.

4. Ren Y, Liu Y, Sun X, Deng K, Wang C, Li L, et al. Hypertriglyceridemia-waist and risk of developing type 2 diabetes: the Rural Chinese Cohort Study. Sci Rep. 2017; 7:9072. PMID: 28831093.

5. Aslam M, Aggarwal S, Sharma KK, Galav V, Madhu SV. Postprandial hypertriglyceridemia predicts development of insulin resistance glucose intolerance and type 2 diabetes. PLoS One. 2016; 11:e0145730. PMID: 26808523.

6. Ford ES, Li C, Zhao G, Pearson WS, Mokdad AH. Hypertriglyceridemia and its pharmacologic treatment among US adults. Arch Intern Med. 2009; 169:572–578. PMID: 19307519.

7. Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA. 2007; 298:309–316. PMID: 17635891.